Insider Transactions in Q1 2021 at Sea Spine Holdings Corp (SPNE)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
42
-0.07%
|
$714
$17.4 P/Share
|
|
Mar 31
2021
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
933
+1.45%
|
-
|
|
Mar 31
2021
|
Kirtley C. Stephenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,077
+1.1%
|
-
|
|
Mar 31
2021
|
Stuart Essig Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,293
+0.3%
|
-
|
|
Mar 31
2021
|
Renee Gaeta Director |
BUY
Grant, award, or other acquisition
|
Direct |
718
+3.6%
|
-
|
|
Mar 08
2021
|
Renee Gaeta Director |
SELL
Open market or private sale
|
Direct |
2,920
-13.61%
|
$52,560
$18.28 P/Share
|
|
Feb 22
2021
|
Renee Gaeta Director |
SELL
Open market or private sale
|
Direct |
3,000
-12.27%
|
$51,000
$17.76 P/Share
|
|
Jan 01
2021
|
John J. Bostjancic Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,851
-12.2%
|
$218,467
$17.45 P/Share
|
|
Jan 01
2021
|
John J. Bostjancic Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,471
+7.28%
|
-
|
|
Jan 01
2021
|
Patrick L Keran SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,308
-14.24%
|
$192,236
$17.45 P/Share
|
|
Jan 01
2021
|
Patrick L Keran SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,540
+8.32%
|
-
|
|
Jan 01
2021
|
Dennis Cirino SVP, Global Spinal Systems |
SELL
Payment of exercise price or tax liability
|
Direct |
5,137
-16.23%
|
$87,329
$17.45 P/Share
|
|
Jan 01
2021
|
Dennis Cirino SVP, Global Spinal Systems |
BUY
Exercise of conversion of derivative security
|
Direct |
8,773
+12.98%
|
-
|
|
Jan 01
2021
|
John J. Winge Vice President, Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
9,090
-10.51%
|
$154,530
$17.45 P/Share
|
|
Jan 01
2021
|
John J. Winge Vice President, Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
18,939
+7.08%
|
-
|
|
Jan 01
2021
|
Keith Valentine Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,450
-7.75%
|
$432,650
$17.45 P/Share
|
|
Jan 01
2021
|
Keith Valentine Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,399
+4.72%
|
-
|
|
Jan 01
2021
|
Tyler Lipschultz SVP, Orthobiologics and BD |
SELL
Payment of exercise price or tax liability
|
Direct |
11,349
-9.35%
|
$192,933
$17.45 P/Share
|
|
Jan 01
2021
|
Tyler Lipschultz SVP, Orthobiologics and BD |
BUY
Exercise of conversion of derivative security
|
Direct |
24,477
+6.59%
|
-
|